Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels.Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases.Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.